Paul Tudor Jones II

Tudor Investment

Paul Tudor Jones II is an influential American hedge fund manager and investor, best known for founding Tudor Investment Corporation in 1980. With a career spanning over four decades, he has gained recognition for his macro trading strategies and philanthropic efforts, particularly through the Robin Hood Foundation, which he co-founded to combat poverty. As of July 2024, his estimated net worth stands at $8.1 billion, reflecting his success in the financial sector. Tudor Investment Corporation, headquartered in Stamford, Connecticut, employs a diversified investment approach, focusing on macroeconomic trends and market dislocations. The firm is known for its active trading style, which includes position adjustments based on market conditions. This strategy is evident in their latest disclosures, which show a dynamic trading record characterized by both position reductions and increases across various sectors, particularly in Financial Services and Technology. The disclosed trading record for Tudor Investment reveals a significant level of activity, with 200 disclosures reported as of May 15, 2026. The firm has executed 96 position increases and 85 reductions, with the largest disclosed move being a trim of approximately $1.24 billion in the iShares Russell 2000 ETF (IWM). This pattern of strategic adjustments underscores the firm's commitment to navigating market fluctuations effectively.

Biggest Wins

PositionReported PriceLast PriceEst. P/LReturnEst. Value
Agilon Health, Inc.AGL · Q1 2026$7.91$124.29+$4M+1,471.3%$4M
Elme CommunitiesWRE · Q1 2026$2.01$17.57+$10M+774.1%$12M
Backblaze, Inc.BLZE · Q1 2026$3.45$13.28+$2M+284.9%$3M
Overstock.com, Inc.OSTK · Q1 2026$4.64$16.78+$6M+261.6%$9M
Micron Technology IncMU · Q1 2026$337.84$983.12+$229M+191%$349M
Digital Turbine, Inc.APPS · Q1 2026$2.88$8.34+$3M+189.4%$5M
Sezzle Inc.SEZL · Q1 2026$63.29$180.44+$3M+185.1%$4M
Astera Labs, Inc. Common StockALAB · Q1 2026$109.60$308.91+$7M+181.9%$12M
Advanced Micro Devices IncAMD · Q1 2026$203.43$548.13+$185M+169.4%$294M
Schweitzer-Mauduit International, Inc.SWM · Q1 2026$8.70$23.41+$5M+169.1%$8M
Clover Health Investments, Corp.CLOV · Q1 2026$1.76$4.50+$524k+155.7%$861k
AGNC Investment Corp. 8.75% Series H Fixed-Rate Cumulative Redeemable Preferred StockAGNCZ · Q1 2026$10.03$25.25+$40M+151.7%$66M
Oscar Health, Inc.OSCR · Q1 2026$11.47$28.86+$30M+151.6%$50M
MARAVAI LIFESCIENS HLDGS INCMRVI · Q1 2026$2.83$7.09+$2M+150.5%$3M
Evolent Health, Inc.EVH · Q1 2026$2.28$5.67+$349k+148.7%$583k
Sandisk CorporationSNDK · Q1 2026$635.34$1,554.39+$61M+144.7%$103M
Personalis, Inc.PSNL · Q1 2026$6.37$15.58+$2M+144.6%$3M
CREDO TECH GROUP HOLDING LTDCRDO · Q1 2026$93.87$226.74+$8M+141.5%$14M
Aehr Test SystemsAEHR · Q1 2026$37.08$87.79+$2M+136.8%$4M
Dell Technologies IncDELL · Q1 2026$164.13$381.71+$31M+132.6%$55M
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX · Q1 2026$36.32$83.90+$2M+131%$4M
United Microelectronics CorporationUMC · Q1 2026$8.98$20.72+$206k+130.7%$364k
Humana Inc.HUM · Q1 2026$173.39$398.42+$5M+129.8%$9M
Intel CorpINTC · Q1 2026$44.13$99.98+$38M+126.6%$67M
Organon & CoOGN · Q1 2026$5.99$13.49+$281k+125.2%$506k
ZipRecruiter, Inc.ZIP · Q1 2026$1.84$4.11+$1M+123.4%$2M
Corcept Therapeutics IncorporatedCORT · Q1 2026$40.31$89.57+$1M+122.2%$2M
Boston Omaha CorporationBOMN · Q1 2026$11.68$25.76+$413k+120.5%$755k
Varonis Systems, Inc.VRNS · Q1 2026$21.47$47.33+$720k+120.4%$1M
CrowdStrike Holdings, Inc.CRWD · Q1 2026$97.60$210.73+$54M+115.9%$100M
WhiteFiber, Inc. Ordinary SharesWYFI · Q1 2026$11.91$25.15+$944k+111.2%$2M
CEVA, Inc.CEVA · Q1 2026$18.68$38.52+$311k+106.2%$604k
Liquidia CorporationLQDA · Q1 2026$37.74$77.75+$2M+106%$3M
Seagate Technology Holdings plcSTX · Q1 2026$391.76$802.45+$42M+104.8%$82M
Hyliion Holdings Corp.HYLN · Q1 2026$1.76$3.60+$546k+104.3%$1M
GH Research PLCGHRS · Q1 2026$14.06$28.71+$272k+104.2%$533k
Centene Corp.CNC · Q1 2026$32.74$66.59+$56M+103.4%$110M
Cryoport IncCYRX · Q1 2026$8.28$16.78+$3M+102.7%$6M
NeoGenomics, Inc.NEO · Q1 2026$7.42$14.84+$132k+100%$264k
Ichor Holdings LtdICHR · Q1 2026$46.61$93.17+$588k+99.9%$1M
Helen of Troy LimitedHELE · Q1 2026$14.42$28.67+$751k+98.8%$2M
JFrog Ltd.FROG · Q1 2026$46.93$92.67+$260k+97.5%$526k
Extreme Networks, Inc.EXTR · Q1 2026$15.08$29.76+$5M+97.3%$9M
Marvell Technology, Inc.MRVL · Q1 2026$99.05$194.94+$12M+96.8%$24M
Spyre Therapeutics, Inc.SYRE · Q1 2026$50.44$98.95+$406k+96.2%$828k
Zentalis Pharmaceuticals, Inc.ZNTL · Q1 2026$2.34$4.57+$78k+95.3%$159k
Navan, Inc.NAVN · Q1 2026$13.24$25.80+$3M+94.9%$6M
AbCellera Biologics Inc.ABCL · Q1 2026$3.49$6.74+$7M+93.1%$15M
Porch Group, Inc.PRCH · Q1 2026$7.17$13.80+$138k+92.5%$287k
Flex LtdFLEX · Q1 2026$65.46$125.75+$4M+92.1%$9M